where is the glp 1 receptor located GLP-1/glucagon co-agonism for treatment of obesity | Diabetologia GLP-1 and the kidney: from

This study investigated whether GLP-1 []

In a new strategy for preventing heart attacks and strokes, leading cardiologists are urging their fellow physicians to focus on reducing the LDL cholesterol of patients at greatest risk of suffering a cardiovascular crisis, and to use costly new drugs if necessary.

RegenMD prescribes compounded GLP-1 therapy with personalized dosing tailored to your body and goals

Each week the mother of two injects herself with weight-loss drugs, two of wh...

Though these drugs have been deemed effective in treating T2DM, the Food and Drug Administration (FDA) and some members of the scientific community have questioned the safety of these therapeutics relative to important cardiovascular endpoints